These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 9013416

  • 1. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K, Dluzen DE.
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 3. Alteration in L-DOPA evoked dopamine and DOPAC output under conditions of impaired vesicular dopamine storage.
    Xu K, Dluzen DE.
    J Neural Transm (Vienna); 1998 Dec; 105(10-12):1091-101. PubMed ID: 9928880
    [Abstract] [Full Text] [Related]

  • 4. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
    Lorenc-Koci E, Czarnecka A, Lenda T, Kamińska K, Konieczny J.
    Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
    [Abstract] [Full Text] [Related]

  • 5. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S, Herregodts P, Deleu D, Devrieze A, De Klippel N, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
    [Abstract] [Full Text] [Related]

  • 6. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS, Choi HS, Zhao TT, Suh KH, Kwon IH, Choi SO, Lee MK.
    Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311
    [Abstract] [Full Text] [Related]

  • 7. Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.
    Del-Bel E, Padovan-Neto FE, Szawka RE, da-Silva CA, Raisman-Vozari R, Anselmo-Franci J, Romano-Dutra AC, Guimaraes FS.
    Neurotox Res; 2014 Jan; 25(1):33-44. PubMed ID: 23807548
    [Abstract] [Full Text] [Related]

  • 8. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 9. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 10. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
    Finberg JP, Wang J, Goldstein DS, Kopin IJ, Bankiewicz KS.
    J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
    [Abstract] [Full Text] [Related]

  • 11. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 12. The Effect of Chronic Treatment with the Inhibitor of Phosphodiesterase 5 (PDE5), Sildenafil, in Combination with L-DOPA on Asymmetric Behavior and Monoamine Catabolism in the Striatum and Substantia Nigra of Unilaterally 6-OHDA-Lesioned Rats.
    Lorenc-Koci E, Kamińska K, Lenda T, Konieczny J.
    Molecules; 2024 Sep 11; 29(18):. PubMed ID: 39339313
    [Abstract] [Full Text] [Related]

  • 13. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990 Sep 11; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

  • 14. Acute L: -DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats.
    Nowak P, Kostrzewa RA, Skaba D, Kostrzewa RM.
    Neurotox Res; 2010 Apr 11; 17(3):299-304. PubMed ID: 19760476
    [Abstract] [Full Text] [Related]

  • 15. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G.
    Life Sci; 2006 Mar 20; 78(17):1940-4. PubMed ID: 16216278
    [Abstract] [Full Text] [Related]

  • 16. MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats.
    Jonkers N, Sarre S, Ebinger G, Michotte Y.
    Eur J Pharmacol; 2000 Nov 03; 407(3):281-91. PubMed ID: 11068024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T.
    Neurobiol Dis; 2006 Jun 03; 22(3):586-98. PubMed ID: 16531050
    [Abstract] [Full Text] [Related]

  • 19. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 03; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 Jul 03; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.